{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:59:08Z","timestamp":1793411948852,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xops.2024.100570","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:01:07Z","timestamp":1719619267000},"page":"100570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"4","author":[{"given":"Gabriella","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Struyven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried K.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Balaskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiarnan D.L.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-745X","authenticated-orcid":false,"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2024.100570_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2020.06.038","article-title":"Retinal specialist versus artificial intelligence detection of retinal fluid from OCT: Age-Related Eye Disease Study 2 10-Year Follow-On Study","volume":"128","author":"Keenan","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib2","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1167\/iovs.08-1689","article-title":"Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration","volume":"49","author":"Keane","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2024.100570_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/IAE.0000000000000483","article-title":"Identification of fluid on optical coherence tomography by treating ophthalmologists versus a reading center in the comparison of age-related macular degeneration treatments trials","volume":"35","author":"Toth","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100570_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib5","first-page":"1012","article-title":"Segmentation of retinal fluid based on deep learning: application of three-dimensional fully convolutional neural networks in optical coherence tomography images","volume":"12","author":"Li","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmpb.2019.04.027","article-title":"Double-branched and area-constraint fully convolutional networks for automated serous retinal detachment segmentation in SD-OCT images","volume":"176","author":"Gao","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.xops.2024.100570_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.media.2019.02.011","article-title":"Deep-learning based multiclass retinal fluid segmentation and detection in optical coherence tomography images using a fully convolutional neural network","volume":"54","author":"Lu","year":"2019","journal-title":"Med Image Anal"},{"key":"10.1016\/j.xops.2024.100570_bib8","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1364\/BOE.8.003440","article-title":"Deep-learning based, automated segmentation of macular edema in optical coherence tomography","volume":"8","author":"Lee","year":"2017","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.xops.2024.100570_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ophtha.2020.03.010","article-title":"Application of automated quantification of fluid volumes to anti-VEGF therapy of neovascular age-related macular degeneration","volume":"127","author":"Schmidt-Erfurth","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2020.12.012","article-title":"Automated quantitative assessment of retinal fluid volumes as important biomarkers in neovascular age-related macular degeneration","volume":"224","author":"Keenan","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2024.100570_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","article-title":"Fully automated detection and quantification of macular fluid in OCT using deep learning","volume":"125","author":"Schlegl","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2018.04.007","article-title":"Automated segmentation of lesions including subretinal hyperreflective material in neovascular age-related macular degeneration","volume":"191","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","article-title":"Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning","volume":"128","author":"Moraes","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.10.3.29","article-title":"Longitudinal higher-order OCT assessment of quantitative fluid dynamics and the total retinal fluid index in neovascular AMD","volume":"10","author":"Ehlers","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2024.100570_bib16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ophtha.2008.08.016","article-title":"Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration","volume":"115","author":"Keane","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamaophthalmol.2021.2273","article-title":"Validation and clinical applicability of whole-volume automated segmentation of optical coherence tomography in retinal disease using deep learning","volume":"139","author":"Wilson","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027441","article-title":"One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource","volume":"9","author":"Fasler","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.xops.2024.100570_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/bjophthalmol-2019-314446","article-title":"Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration","volume":"104","author":"Fasler","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41591-020-0867-7","article-title":"Predicting conversion to wet age-related macular degeneration using deep learning","volume":"26","author":"Yim","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.xops.2024.100570_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/bjophthalmol-2020-317416","article-title":"Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy","volume":"106","author":"Michl","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ophtha.2012.10.014","article-title":"Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration","volume":"120","author":"Busbee","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A\u00a0variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study","volume":"148","author":"Lalwani","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib25","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xops.2024.100570_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","article-title":"Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study","volume":"9","author":"Lai","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2024.100570_bib27","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1109\/TMI.2019.2901398","article-title":"RETOUCH: the retinal OCT fluid detection and segmentation benchmark and challenge","volume":"38","author":"Bogunovic","year":"2019","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.xops.2024.100570_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ophtha.2018.11.025","article-title":"Tolerating subretinal fluid in neovascular age-related macular degeneration treated with ranibizumab using a treat-and-extend regimen: FLUID Study 24-Month Results","volume":"126","author":"Guymer","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.oret.2022.03.024","article-title":"Predominantly persistent intraretinal fluid in the comparison of age-related macular degeneration treatments trials","volume":"6","author":"Core","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100570_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00006982-199805000-00031","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"18","author":"Tolentino","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100570_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.oret.2021.06.003","article-title":"Predominantly persistent subretinal fluid in the comparison of age-related macular degeneration treatments trials","volume":"5","author":"Core","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100570_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib33","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/eye.2016.227","article-title":"A\u00a0view of the current and future role of optical coherence tomography in the management of age-related macular degeneration","volume":"31","author":"Schmidt-Erfurth","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.xops.2024.100570_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ajo.2016.03.039","article-title":"Response of pigment epithelial detachment to anti\u2013vascular endothelial growth factor treatment in age-related macular degeneration","volume":"166","author":"Cho","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17469899.2020.1745062","article-title":"Hyperreflective material as a biomarker in neovascular age-related macular degeneration","volume":"15","author":"Casalino","year":"2020","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2024.100570_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ophtha.2019.11.010","article-title":"Anti\u2013vascular endothelial growth factor use and atrophy in neovascular age-related macular degeneration: systematic literature review and expert opinion","volume":"127","author":"Sadda","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2013.08.015","article-title":"Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Grunwald","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib41","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ophtha.2020.03.031","article-title":"Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration","volume":"127","author":"Sadda","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib42","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ophtha.2015.10.034","article-title":"Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT)","volume":"123","author":"Daniel","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ophtha.2016.09.012","article-title":"Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials","volume":"124","author":"Grunwald","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ophtha.2018.07.013","article-title":"Intralesional macular atrophy in anti\u2013vascular endothelial growth factor therapy for age-related macular degeneration in the IVAN trial","volume":"126","author":"Bailey","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2024.100570_bib45","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/bjophthalmol-2020-318688","article-title":"Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy","volume":"106","author":"Zarbin","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2024.100570_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","article-title":"A\u00a0paradigm shift in imaging biomarkers in neovascular age-related macular degeneration","volume":"50","author":"Schmidt-Erfurth","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2024.100570_bib47","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/IAE.0000000000000465","article-title":"Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal ranizubimab: functional and structural outcome","volume":"35","author":"Gianniou","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100570_bib48","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1038\/s41598-020-64901-9","article-title":"Impact of sub-retinal fluid on the long-term incidence of macular atrophy in neovascular age-related macular degeneration under treat & extend anti-vascular endothelial growth factor inhibitors","volume":"10","author":"Siedlecki","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2024.100570_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000342159","article-title":"Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration","volume":"229","author":"Coscas","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2024.100570_bib50","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/IAE.0000000000001033","article-title":"Prognostic value of hyperreflective foci in neovascular age-related macular degeneration treated with bevacizumab","volume":"36","author":"Segal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100570_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/IAE.0000000000000645","article-title":"Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after anti-VEGF treatment in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2024.100570_bib52","article-title":"Imaging hyperreflective foci as an inflammatory biomarker after anti-VEGF treatment in neovascular age-related macular degeneration patients with optical coherence tomography angiography","volume":"2021","author":"Wu","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.xops.2024.100570_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206482","article-title":"Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema","volume":"13","author":"Schreur","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.xops.2024.100570_bib54","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1167\/iovs.10-5779","article-title":"Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration","volume":"51","author":"Framme","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914524001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:03:14Z","timestamp":1732698194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914524001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666914524001064"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2024.100570","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2024.100570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100570"}}